Noble Financial set a $19.00 price target on electroCore (NASDAQ:ECOR) in a research note issued to investors on Friday, TipRanks reports. The brokerage currently has a buy rating on the stock.
A number of other equities analysts have also recently commented on the stock. Cantor Fitzgerald dropped their price objective on shares of electroCore from $23.00 to $19.00 and set an overweight rating for the company in a research note on Wednesday, May 15th. BTIG Research cut shares of electroCore from a buy rating to a neutral rating in a research note on Wednesday, May 15th. Finally, Zacks Investment Research raised shares of electroCore from a sell rating to a hold rating in a research note on Monday, May 13th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. electroCore presently has a consensus rating of Buy and an average price target of $20.25.
ECOR opened at $3.12 on Friday. The firm has a market cap of $88.89 million and a P/E ratio of -2.62. electroCore has a fifty-two week low of $2.82 and a fifty-two week high of $20.25. The company has a debt-to-equity ratio of 0.08, a current ratio of 10.74 and a quick ratio of 10.00.
In other electroCore news, insider Joseph P. Errico sold 39,592 shares of electroCore stock in a transaction on Friday, April 12th. The shares were sold at an average price of $5.52, for a total value of $218,547.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Joseph P. Errico sold 10,408 shares of the firm’s stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $6.97, for a total transaction of $72,543.76. The disclosure for this sale can be found here.
Several institutional investors have recently added to or reduced their stakes in ECOR. New York State Common Retirement Fund bought a new stake in shares of electroCore in the 4th quarter worth about $41,000. American International Group Inc. lifted its holdings in shares of electroCore by 95.3% in the 1st quarter. American International Group Inc. now owns 7,759 shares of the company’s stock worth $54,000 after acquiring an additional 3,787 shares during the last quarter. Wsfs Capital Management LLC bought a new stake in shares of electroCore in the 4th quarter worth about $63,000. Rhumbline Advisers bought a new stake in shares of electroCore in the 1st quarter worth about $73,000. Finally, Two Sigma Investments LP bought a new stake in electroCore during the 4th quarter valued at about $85,000. Hedge funds and other institutional investors own 14.09% of the company’s stock.
electroCore, Inc, a bioelectronic medicine company, engages in developing a range of patient-administered non-invasive vagus nerve (VNS) stimulation therapies for the treatment of various conditions in neurology, rheumatology, and other fields. The company is developing gammaCore, a prescription-only non-invasive VNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults.
Recommended Story: Investing in Blue-Chip Stocks
Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.